Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

NCT05303519

Conditions
Astrocytoma, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, +22 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
View all 61 locations
View Trial Details
Recruiting

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

NCT06375044

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Dana Farber Cancer institution Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View all 16 locations
View Trial Details
Recruiting

A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

NCT06285318

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Aalborg Sygehus Syd Aalborg, Denmark
  • Aarhus Universitetshospital Aarhus N, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
View all 68 locations
View Trial Details
Recruiting

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT07365306

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +16 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Atlanta Cancer Center Newnan, Georgia, United States
  • City of Hope at Chicago Zion, Illinois, United States
View Trial Details
Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

NCT07589634

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Ampang Ampang, Malaysia
  • Beverly Hills Cancer Center (BHCC) Beverly Hills, California, United States
  • Hospital Sultanah Aminah Johor Bharu, Malaysia
  • Sarawak General Hospital Kuching, Malaysia
View Trial Details
Recruiting

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

NCT06648889

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University Hospital Augsburg, II. Medizinischen Klinik, Hämatologie, internistische Onkologie und Hämostaseologie Augsburg, Germany
  • Charité Berlin, Campus Benjamin Franklin, Department of Hematology, Oncology and Tumorimmunologyt Hämatologie Berlin, Germany
  • Gesundheit Nord Klinikverbund Bremen gGmbH, Klinikum Bremen-Mitte, Med. Klinik I Bremen, Germany
  • Klinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany
View all 15 locations
View Trial Details

Related conditions